
Get to know us
Founded in 2021, Veloxity Labs is proudly an employee-owned and operated bioanalytical contract research organization.
Meet The Team
About
Veloxity Labs
Veloxity Labs is a bioanalytical contract research organization (CRO) specializing in services to help companies develop therapeutics to treat disease. Our expertise spans both non-regulated and GxP analysis of non-clinical and clinical samples. We also have expertise supporting microsampling and patient-centric sampling using Mitra , Tasso, and dried blood spot (DBS) technology. We can address your bioanalytical services needs across different modalities, including small molecules and peptides, large molecules, antibody-drug conjugates and others, with applications to support pharmaceutical, biotech and animal health industries. We help our clients succeed by starting projects quickly and providing fast turnaround with high-quality data.
®
Meet our leadership team
Meet our Advisory Board

Binodh DeSilva
Senior Vice President
Ultragenyx

Stephanie Rosenberg
Director, Sales & Marketing
Advanced Materials Technology

David Reynolds
Director, Bioanalytical Chemistry and DMPK
BioCryst Pharmaceuticals

Vivian Standifird
Executive Director
Peoria Bio-Made Foundation

Debi Garvin
President and CEO
Pacific Rim GLP Consulting

Gina Patel
President and CEO
Patel Kwan Consultancy

Don Schwegel
Vice President
Morton Community Bank

Lisa Shipley
Founder
Shipley Pharma Insights

Perry Cao
Bioanalytical Expert and Consultant
%20DSC_0335.jpg)
Jane Owens
Drug Development Consultant

Andy Vick
Vice President, Head of Toxicology, Drug Disposition, and PKPD
Attralus Therapeutics

Todd Gillespie
Sr. Research Advisor, Product Research & Development
Eli Lilly
.png)
Lucinda R. Hittle
President of Discovery & Development
Insights, LLC